Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Han, Hyun Ja ^a,c   Kuwae, Asaomi ^b   Abe, Akio ^b   Arakawa, Yoshichika ^a   Kamachi, Kazunari ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c National Fisheries Research and Development Institute (NFRDI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PERTUSSIS VACCINE; PROTEIN; TYPE III CYTOTOXIC EFFECTOR BTEA PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; MESSENGER RNA;

5' UNTRANSLATED REGION; ARTICLE; BACTERIAL STRAIN; BORDETELLA BRONCHISEPTICA INFECTION; BORDETELLA PERTUSSIS; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; GENE INSERTION; HOST CELL; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SEQUENCE ANALYSIS; START CODON; CHROMOSOME MAP; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; TRANSCRIPTION INITIATION SITE;

BORDETELLA BRONCHISEPTICA; BORDETELLA PERTUSSIS;

5' UNTRANSLATED REGIONS; BACTERIAL PROTEINS; BASE SEQUENCE; BORDETELLA PERTUSSIS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTATION; PERTUSSIS VACCINE; PHYSICAL CHROMOSOME MAPPING; PROMOTER REGIONS, GENETIC; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 79952514269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017797     Document Type: Article

References (46)

1. Mattoo S, Cherry JD, (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-382.
2. Andrews R, Herceg A, Roberts C, (1997) Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell 21: 145-148.
3. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rümke HC, et al. (2000) Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 6: 348-357.
4. Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, et al. (2009) The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 9: 22.
5. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, et al. (2003) Trends in pertussis among infants in the United States, 1980-1999. JAMA 290: 2968-2975.
6. Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernández J, et al. (2007) Pulsed-field gene electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 14: 1490-1498.
7. Fry NK, Neal S, Harrison TG, Miller E, Matthews R, et al. (2001) Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun 69: 5520-5528.
8. Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y, (2004) Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol 42: 5453-5457.
9. Litt DJ, Neal SE, Fry NK, (2009) Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 47: 680-688.
10. Tsang RSW, Lau AKH, Sill ML, Halperin SA, Van Caeseele P, et al. (2004) Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 42: 5364-5367.
11. van Amersfoorth SCM, Schouls LM, van der Heide HGJ, Advani A, Hallander HO, et al. (2005) Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43: 2834-2843.
12. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, et al. (2007) Antigenic divergence between Bordetella pertussis clinical isolates from the Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 14: 234-238.
13. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, et al. (2000) Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 182: 1402-1408.
14. He Q, Mäkinen J, Berbers G, Mooi FR, Viljanen MK, et al. (2003) Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis 187: 1200-1205.
15. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, et al. (1998) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66: 670-675.
16. Cummings CA, Bootsma HJ, Relman DA, Miller JF, (2006) Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 188: 1775-1785.
17. Shrivastava R, Miller JF, (2009) Virulence factor secretion and translocation by Bordetella species. Curr Opin Microbiol 12: 88-93.
18. Mattoo S, Yuk MH, Huang LL, Miller JF, (2004) Regulation of type III secretion in Bordetella. Mol Microbiol 52: 1201-1214.
19. Yuk MH, Harvill ET, Miller JF, (1998) The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol 28: 945-959.
20. Coburn B, Sekirov I, Finlay BB, (2007) Type III secretion system and disease. Clin Microbiol Rev 20: 535-549.
21. Ghosh P, (2004) Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev 68: 771-795.
22. Fennelly NK, Sisti F, Higgins SC, Ross PJ, van der Heide H, et al. (2008) Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun 76: 1257-1266.
23. Nagamatsu K, Kuwae A, Konaka T, Nagai S, Yoshida S, et al. (2009) Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med 206: 3073-3088.
24. Medhekar B, Shrivastava R, Mattoo S, Gingery M, Miller JF, (2009) Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo. Mol Microbiol 71: 492-504.
25. Caro V, Bouchez V, Guiso N, (2008) Is the sequenced Bordetella pertussis strain Tohama I representative of the species? J Clin Microbiol 46: 2125-2128.
26. Heikkinen E, Kallonen T, Saarinen L, Sara R, King AJ, et al. (2007) Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS ONE 2: e904.
27. King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, et al. (2008) Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 9: 311.
28. Vidakovics MLP, Paba J, Lamberti Y, Ricart CA, de Sousa MV, et al. (2007) Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 6: 2518-2528.
29. Panina EM, Mattoo S, Griffith N, Kozak NA, Yuk MH, et al. (2005) A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species. Mol Microbiol 58: 267-279.
30. Kuwae A, Matsuzawa T, Ishikawa N, Abe H, Nonaka T, et al. (2006) BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in the type III-dependent necrotic cell death. J Biol Chem 281: 6589-6600.
31. French CT, Panina EM, Yea SH, Griffith N, Arambula DG, et al. (2009) The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol 11: 1735-1749.
32. Nogawa H, Kuwae A, Matsuzawa T, Abe A, (2004) The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for formation on the host plasma membrane. J Bacteriol 186: 3806-3813.
33. Stibitz S, (1998) IS481 and IS1002 of Bordetella pertussis create a 6-base-pair duplication upon insertion at a consensus target site. J Bacteriol 180: 4963-4966.
34. DeShazer D, Wood GE, Friedman RL, (1994) Molecular characterization of catalase from Bordetella pertussis: identification of the katA promoter in an upstream insertion sequence. Mol Microbiol 14: 123-130.
35. Kozak NA, Panina EM, Miller JF, (2007) Type III secretion in Bordetella subspecies. In: Locht C, editors. Bordetella: molecular microbiology Norfolk, United Kingdom Horizon Scientific Press pp. 119-140.
36. Han H-J, Kamachi K, Okada K, Toyoizumi-Ajisaka H, Sasaki Y, et al. (2008) Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine 26: 1530-1534.
37. Mooi FR, van Loo IHM, van Gent M, He Q, Bart MJ, et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15: 1206-1213.
38. Craig NL, Craigie R, Gellert M, Lambowitz AM, (2002) Mobile DNA II. Washington DC ASM Press.
39. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32-40.
40. Caro V, Hot D, Guigon G, Hubans C, Arrivé M, et al. (2006) Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect 8: 2228-2235.
41. Kaberdin VR, Bläsi U, (2006) Translation initiation and the fate of bacterial mRNAs. FEMS Microbiol Rev 30: 967-979.
42. Pradel E, Guiso N, Menozzi FD, Locht C, (2000) Bordetella pertussis TonB, a Bvg-independent virulence determinant. Infect Immun 68: 1919-1927.
43. O'Farrell PH, (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021.
44. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
45. Stefanelli P, Sanguinetti M, Fazio C, Posteraro B, Fadda G, et al. (2006) Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates. J Clin Microbiol 44: 3397-3400.
46. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, et al. (2001) Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A 25: 11638-11643.